These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8618231)

  • 1. Biochemical modulation of fluoropyrimidines: is there an optimal (6R,S) leucovorin dose and schedule?
    Doroshow JH
    J Natl Cancer Inst; 1996 Apr; 88(7):393-5. PubMed ID: 8618231
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma.
    Cao S; Frank C; Rustum YM
    J Natl Cancer Inst; 1996 Apr; 88(7):430-6. PubMed ID: 8618234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The French experience with infusional 5-fluorouracil in advanced colorectal cancer.
    de Gramont A; Louvet C; Krulik M
    J Infus Chemother; 1996; 6(3):133-6. PubMed ID: 9229324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)].
    de Gramont A; Louvet C; André T; Tournigand C; Raymond E; Molitor JL; Krulik M
    Rev Med Interne; 1997; 18 Suppl 4():372s-378s. PubMed ID: 9365715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimetrexate as a biochemical modulator of 5-fluorouracil and leucovorin in colorectal cancer.
    Punt CJ
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):88-90. PubMed ID: 11049038
    [No Abstract]   [Full Text] [Related]  

  • 6. [Systemic palliative chemotherapy with 5-fluorouracil and leucovorin in disseminated colorectal cancer].
    Wiboltt K; Raskov HH
    Ugeskr Laeger; 1999 Jun; 161(25):3827-32. PubMed ID: 10412300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.
    Sobrero A; Guglielmi A; Grossi F; Puglisi F; Aschele C
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):72-7. PubMed ID: 11049035
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival.
    Zaniboni A
    J Clin Oncol; 1997 Jun; 15(6):2432-41. PubMed ID: 9196159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On 5-fluorouracil therapy of colorectal cancer.
    Jensen SA
    Dan Med J; 2013 Jul; 60(7):B4603. PubMed ID: 23809976
    [No Abstract]   [Full Text] [Related]  

  • 10. Developments of the fluoropyrimidines as inhibitors of thymidylate synthetase: pharmacologic and clinical aspects.
    Machover D
    J Surg Oncol Suppl; 1991; 2():42-50. PubMed ID: 1832540
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral doxifluridine plus leucovorin in metastatic colorectal cancer: randomized phase II trial with intravenous 5-fluorouracil plus leucovorin.
    Ahn JH; Kim TW; Lee JH; Min YJ; Kim JG; Kim JC; Yu CS; Kim WK; Kang YK; Lee JS
    Am J Clin Oncol; 2003 Feb; 26(1):98-102. PubMed ID: 12576934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer.
    Buyse M; Thirion P; Carlson RW; Burzykowski T; Molenberghs G; Piedbois P
    Lancet; 2000 Jul; 356(9227):373-8. PubMed ID: 10972369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral fluoropyrimidines in colorectal cancer.
    Van Cutsem E; Peeters M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor 5-FU-related mRNA Expression and Efficacy of Oral Fluoropyrimidines in Adjuvant Chemotherapy of Colorectal Cancer.
    Koda K; Miyauchi H; Kosugi C; Kaiho T; Takiguchi N; Kobayashi S; Maruyama T; Matsubara H;
    Anticancer Res; 2016 Oct; 36(10):5325-5331. PubMed ID: 27798895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant treatment of carcinoma of the colon].
    Zaniboni A
    Tumori; 2000; 86(3 Suppl):S23-4. PubMed ID: 10969611
    [No Abstract]   [Full Text] [Related]  

  • 17. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
    Aranda E; Cervantes A; Carrato A; Antón-Torres A; Massutí T; Fernández-Martos C; Díaz-Rubio E
    J Infus Chemother; 1996; 6(3):118-22. PubMed ID: 9229321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
    Schwartzberg LS; Petak I; Stewart C; Turner PK; Ashley J; Tillman DM; Douglas L; Tan M; Billups C; Mihalik R; Weir A; Tauer K; Shope S; Houghton JA
    Clin Cancer Res; 2002 Aug; 8(8):2488-98. PubMed ID: 12171874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III study.
    Scheithauer W; Kornek G; Marczell A; Salem G; Karner J; Kovats E; Burger D; Greiner R; Pidlich J; Schneeweiss B; Raderer M; Rosen H; Depisch D
    J Clin Oncol; 1997 Mar; 15(3):908-14. PubMed ID: 9060527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of colonic cancer].
    Block S
    Soins; 2010 Mar; (743):46. PubMed ID: 20423037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.